![Michael Marino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/05/2026
Michael Francis Marino currently works at Optinose AS, as Director from 2018 and NewAmsterdam Pharma Co. NV, as Secretary & Chief Legal Officer from 2025.
Mr. Marino also formerly worked at Fibrocell Science, Inc., as Secretary, Senior Vice President & General Counsel from 2015 to 2017, NuPathe, Inc., as Secretary, Senior Vice President & General Counsel from 2013 to 2014, Arthur Andersen LLP, as Auditor, Wilmer Cutler Pickering Hale & Dorr LLP, as Associate, OptiNose, Inc., as Secretary & Chief Legal Officer from 2017 to 2025, Morgan, Lewis & Bockius LLP, as Attorney from 2005 to 2010, and WilmerHale LLP, as Attorney from 2001 to 2005.
Mr. Marino received his undergraduate degree from Villanova University and graduate degree from Boston College Law School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2025 | 55.000 ( 0,05% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Consigliere Generale | 01/05/2025 |
Optinose AS
 Optinose AS Medical SpecialtiesHealth Technology Develops nasal drug delivery systems | Direttore/Membro del Consiglio | 12/07/2018 |
| Società | Posizione | Fine |
|---|---|---|
| OPTINOSE, INC. | Consigliere Generale | 21/05/2025 |
| FIBROCELL SCIENCE, INC. | Consigliere Generale | 25/01/2017 |
| NUPATHE INC | Consigliere Generale | 01/03/2014 |
Morgan, Lewis & Bockius LLP
 Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2010 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and therapeutic products | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology Develops nasal drug delivery systems | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WilmerHale LLP
 WilmerHale LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
